5-Aminolevulinic acid photodynamic therapy is a safe and effective treatment for female patients with intractable vulvar lichen sclerosus

被引:0
|
作者
Zheng, Xiangrong [1 ,2 ]
Liu, Xiaoli [3 ,4 ]
Zhang, Junhua [3 ,4 ]
Liu, Hongli [3 ]
Xu, Ying [3 ]
Meng, Lihua [3 ]
Zhang, Youzhong [3 ]
Wang, Lili [3 ]
Jia, Lin [3 ]
机构
[1] Shandong First Med Univ, Dept Neurosurg, Shandong Prov Hosp, Tai An, Peoples R China
[2] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Jinan, Peoples R China
[3] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan, Peoples R China
[4] Key Lab Gynecol Oncol Shandong Prov, Jinan, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Intractable vulvar lichen sclerosus; 5-aminolevulinic acid; Photodynamic therapy; Conservative treatment; ET-ATROPHICUS; SERIES;
D O I
10.1016/j.pdpdt.2024.104330
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Female vulvar lichen sclerosus (VLS) is a chronic inflammatory skin disease of the vulva and its etiology is unknown. The main clinical symptoms are itching, burning and dyspareunia, and there is a lack of effective treatment. Methods: Clinical and follow-up data of women with VLS who underwent 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) from January 2023 to December 2023 in the department of obstetrics and gynecology, Qilu Hospital of Shandong University, were retrospectively analyzed. According to the inclusion and exclusion criteria, 36 patients with VLS who received ineffective conventional treatment (intractable VLS) were enrolled. Objective signs and subjective symptoms of vulvar lesions were recorded before treatment and 6 months after the end of treatment according to corresponding scoring criteria. Quality of life was evaluated using the Dermatology Life Quality Index (DLQI). Results: All patients received six sessions of ALA-PDT treatment and follow-up visits. After ALA-PDT treatment, 24 of 36 (66.67 %) patients' itching symptoms completely disappeared, 10 of 36 (27.78 %) patients' itching symptoms were relieved from severe to mild, and only 2 of 36 (5.56 %) patients' symptoms were not significantly relieved. 16 of 36 (44.4 %) patients' itching symptoms completely disappeared, 9 of 36 (25 %) patients' itching symptoms were relieved from severe to mild, and only 2 of 36 (5.56 %) patients still had severe pain. Compared to 22 patients with dyspareunia before treatment, only 9 patients still had dyspareunia with varying degrees of dyspareunia relief after treatment. Clinical signs improved significantly in the patients after ALA-PDT treatment. The total scores of clinical signs were (5.31 +/- 1.67 vs 3.67 +/- 1.71) before and after treatment. All patients showed improvement in DLQI after treatment. The main side effects of ALA-PDT were pain, erythema and swelling which were transient and tolerable. All patients were "satisfied" or "very satisfied" with the results of the treatment. Conclusions: ALA-PDT is a safe and effective treatment for women with intractable vulva lichen sclerosus.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid
    Hillemanns, P
    Untch, M
    Pröve, F
    Baumgartner, R
    Hillemanns, M
    Korell, M
    OBSTETRICS AND GYNECOLOGY, 1999, 93 (01): : 71 - 74
  • [2] Evaluation of the efficacy of 5-aminolevulinic acid photodynamic therapy for the treatment of vulvar lichen sclerosus
    Li, Zhijia
    Wang, Yajie
    Wang, Jingying
    Li, Songshan
    Xiao, Zixuan
    Feng, Yingjun
    Gu, Jingjing
    Li, Junpeng
    Peng, Xiaoming
    Li, Changxing
    Zeng, Kang
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2020, 29
  • [3] The efficacy of 5-aminolevulinic acid photodynamic therapy for pediatric vulvar lichen sclerosus
    Zhang, Shan
    Wang, Yukun
    Wang, Juncheng
    Liu, Jie
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 45
  • [4] An open trial of 5-aminolevulinic acid photodynamic therapy for vulvar lichen sclerosus
    Sotiriou, Eleni
    Panagiotidou, Despoina
    Ioannidis, Demetrios
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 141 (02) : 187 - 188
  • [5] Comparison of 5-Aminolevulinic Acid Photodynamic Therapy and Clobetasol Propionate in Treatment of Vulvar Lichen Sclerosus
    Shi, Lei
    Miao, Fei
    Zhang, Ling-Lin
    Zhang, Guo-Long
    Wang, Pei-Ru
    Ji, Jie
    Wang, Xiao-Jie
    Huang, Zheng
    Wang, Hong-Wei
    Wang, Xiu-Li
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (05) : 684 - 688
  • [6] Clinical efficacy analysis of 5-aminolevulinic acid photodynamic therapy for vulvar lichen sclerosus
    Qu, Zhongyu
    Lin, Xueyan
    Liu, Ming
    Wang, Jia
    Wang, Fei
    Zhang, Bei
    Shen, Liang
    Wang, Zhifeng
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 46
  • [7] Efficacy of 5-Aminolevulinic Acid (ALA)-Photodynamic Therapy (PDT) in Refractory Vulvar Lichen Sclerosus: Preliminary Results
    Zhang, Fenghua
    Li, Daoyun
    Shi, Lijuan
    Gu, Yijia
    Xu, Yun
    Wu, Changping
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [8] Clinical and Dermoscopic Assessment of Vulvar Lichen Sclerosus After 5-Aminolevulinic Acid Photodynamic Therapy : A Prospective Study
    Liu, Jie
    Hao, Jianchun
    Wang, Yukun
    Liu, Yuehua
    Xu, Tao
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 33
  • [9] 5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: Series of ten cases
    Lan, Ting
    Zou, Yongzhen
    Hamblin, Michael R.
    Yin, Rui
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2018, 21 : 234 - 238
  • [10] The efficacy and safety of 5-aminolevulinic acid photodynamic therapy for lichen sclerosus: A meta analysis
    Qing, Chun
    Mao, Xiaoyong
    Liu, Gaoqing
    Deng, Yibin
    Yang, Xiaokun
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (01) : 1 - 7